Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 18,813 |
|
|||||
| News | - | ||||||
| Day High | 1.90 | Low High |
|||||
| Day Low | 1.81 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| TRACON Pharmaceuticals Inc | TCON | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0647 | -3.45% | 1.81 | 08:45:38 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.90 | 1.81 | 1.90 | 1.8747 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 178 | 18,813 | US$ 1.88 | US$ 35,370 | - | 1.59 - 16.80 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:49:06 | 22 | US$ 1.90 | USD |
TRACON Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 82.36M | 45.50M | - | 12.05M | -3.59M | -0.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
TRACON Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/07/2024 | 16:03 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 3/05/2024 | 16:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 2/28/2024 | 15:02 | GlobeNewswire Inc. | TRACON to Report Fourth Quarter and Year-End 2023 Financial.. |
| 2/14/2024 | 15:31 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/09/2024 | 15:05 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 12/19/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/08/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/20/2023 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/09/2023 | 16:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/06/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/18/2023 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/07/2023 | 15:11 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TCON Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.82 | 2.10 | 1.70 | 1.84 | 139,800 | -0.01 | -0.55% |
| 1 Month | 8.30 | 8.54 | 1.59 | 4.27 | 2,227,662 | -6.49 | -78.19% |
| 3 Months | 3.992 | 14.746 | 1.59 | 7.25 | 3,514,897 | -2.18 | -54.66% |
| 6 Months | 3.232 | 14.746 | 1.59 | 5.30 | 4,186,636 | -1.42 | -44.00% |
| 1 Year | 16.00 | 16.80 | 1.59 | 5.30 | 2,353,305 | -14.19 | -88.69% |
| 3 Years | 147.20 | 153.20 | 1.59 | 11.56 | 888,634 | -145.39 | -98.77% |
| 5 Years | 13.756 | 244.00 | 1.59 | 33.45 | 751,232 | -11.95 | -86.84% |
TRACON Pharmaceuticals Description
| TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies. |
